Factors Associated With Polypharmacy in Nursing Home Residents
Authors:
- Bruce K. TamuraBTBruce K. Tamura
- Christina L. BellCBChristina L. Bell
- Michiko InabaMIMichiko Inaba
- Kamal H. MasakiKMKamal H. Masaki
- 1 May 2012
- journal article
- review article
- Published by Elsevier in Clinics in Geriatric Medicine
- Vol. 28 (2) , 199-216
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Cholinesterase Inhibitor and Memantine Use in Newly Admitted Nursing Home Residents with DementiaJournal of the American Geriatrics Society, 2011
- Physician Intervention for Medication Reduction in a Nursing Home: The Polypharmacy Outcomes ProjectJournal of the American Medical Directors Association, 2011
- Daily Medication Use in Nursing Home Residents with Advanced DementiaJournal of the American Geriatrics Society, 2010
- Acetylcholinesterase Inhibitor and N-Methyl- D -Aspartic Acid Receptor Antagonist Use among Hospice Enrollees with a Primary Diagnosis of DementiaJournal of Palliative Medicine, 2008
- Exposure to Potentially Inappropriate Drugs and Drug-Drug Interactions in Elderly Nursing Home Residents in Helsinki, FinlandDrugs & Aging, 2008
- Treatment of Dementia in Community‐Dwelling and Institutionalized Medicare BeneficiariesJournal of the American Geriatrics Society, 2007
- Evaluation of the quality of drug therapy among elderly patients in nursing homesScandinavian Journal of Primary Health Care, 2007
- Drug Use in a Geriatric Long-Term Care SettingDrugs & Aging, 2006
- The Prevalence of Dementia in a Statewide Sample of New Nursing Home Admissions Aged 65 and OlderThe Gerontologist, 2000
- Studies of Illness in the AgedJAMA, 1963